<template>
	<div class=WordSection1 style='layout-grid:15.6pt'>

	<p class=MsoNormal align=left style='margin-bottom:10.5pt;text-align:left'><span style='font-size:16.5pt;font-family:"Microsoft YaHei UI",sans-serif;
	color:#333333;letter-spacing:.4pt'>精准医疗：临床诊断产业的全球趋势<span lang=EN-US> | </span>药明康德健康产业论坛速递</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span
	style='font-size:11.5pt;font-family:楷体;color:#0070C0;letter-spacing:.4pt'>▎药明康德<span lang=EN-US>/</span>报道</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>作为精准医疗的主要组成部分，临床诊断，尤其是覆盖传染病、肿瘤、遗传病等各病种的高端特检，近年来发展迅猛。在首届药明康德健康产业论坛上，药明奥测首席执行官刘釜均博士与来自中国、美国和欧洲的四位嘉宾，以“精准医疗：临床诊断产业的全球趋势”为题，聚焦全球创新检测技术的发展，<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>探讨如何打造适合患者的精准检测和治疗方案。</span></strong></span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><b><span lang=EN-US
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'><br>
	</span></b><span lang=EN-US style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;
	color:#333333;letter-spacing:.4pt'><img width=100% id="图片 15"
	src="/images/news/3/image001.png"></span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>主持人：</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>刘釜均博士，药明奥测首席执行官</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>嘉宾：</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span lang=EN-US
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>William Morice</span></strong><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>博士，梅奥医学实验室总裁</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>刘道志博士，山蓝资本创始及执行合伙人</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span lang=EN-US
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>Martien van Osch</span></strong><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>先生，<span lang=EN-US>Forbion</span>管理合伙人</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><strong><span
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>朱耀毅先生，中国医疗器械行业协会体外诊断分会理事长</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt'><strong><span style='font-size:
	11.5pt;font-family:宋体'>近年最激动人心的进展</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span lang=EN-US
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>William Morice</span><span style='font-size:11.5pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'>博士来自享誉全球的梅奥医学实验室（<span
	lang=EN-US>Mayo Clinic Laboratories</span>，<span lang=EN-US> MCL</span>）。他认为，<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>除了在二代测序（<span lang=EN-US>NGS</span>）方面的进展，近年来最令人兴奋的突破是对多组学指标的平行检测，这可以为临床诊断产生海量的数据。</span></strong></span></p>

	<p align=center style='margin:0cm;margin-bottom:.0001pt;text-align:center;
	line-height:21.0pt'><b><span lang=EN-US style='font-size:11.5pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'><img
	width=100% id="图片 9" src="/images/news/3/image002.png"></span></b><b><span
	lang=EN-US style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;
	color:#333333;letter-spacing:.4pt'><br>
	</span></b><strong><span style='font-size:10.5pt;font-family:"Microsoft YaHei UI",sans-serif;
	color:#0070C0;letter-spacing:.4pt'>▲<span lang=EN-US>William Morice</span>博士，梅奥医学实验室总裁</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>中国医疗器械行业协会体外诊断分会会长朱耀毅先生表示，<span lang=EN-US>20</span>年前他曾代表唯一一家中国公司参加美国临床化学年会暨临床实验医学博览会（<span
	lang=EN-US>AACC</span>），而如今，<span lang=EN-US>AACC</span>的中国参展商已超过<span
	lang=EN-US>100</span>家。<strong><span style='font-family:"Microsoft YaHei UI",sans-serif'>中国在体外诊断产业链中的参与度增长从这个数据可见一斑。</span></strong></span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>医疗健康投资基金山蓝资本创始及执行合伙人刘道志博士直言体外诊断已成为投资热点，目前在中国，已有<span lang=EN-US>20</span>家精确诊断上市公司，<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>在医疗器械领域中是上市公司数量最多的细分领域</span></strong>。从科研成果到临床检验、快速诊断的转化时间越来越短，已经成为诊断行业的一个重要趋势。</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'><img width=100% id="图片 14"
	src="/images/news/3/image003.png"></span></p>

	<p align=center style='margin:0cm;margin-bottom:.0001pt;text-align:center;
	line-height:21.0pt'><strong><span style='font-size:10.5pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;letter-spacing:.4pt'>▲刘道志博士，山蓝资本创始及执行合伙人</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>来自<span lang=EN-US>Forbion</span>公司的<span lang=EN-US>Martien van Osch</span>先生指出，<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>液体活检技术的突破令人兴奋</span></strong>，这种检测方法不但可以降低获取样本的成本，而且由于检测的微创性，可以在不同时间点长期跟踪患者状态的变化。</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt'><strong><span style='font-size:
	11.5pt;font-family:宋体'>成功开发临床检测的秘诀</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>作为梅奥诊所的核心竞争力之一，<span lang=EN-US>MCL</span>拥有全美规模最大、水平最高的特检项目群，其拥有的<span
	lang=EN-US>3000</span>余项用于筛查、诊断、治疗和预后评估的检验项目覆盖多组学和各疾病领域，为全球超过<span lang=EN-US>4600</span>家医疗机构提供世界顶尖的临床检验实验及病理学诊断服务。实验室每年进行<span
	lang=EN-US>2500</span>万次检测，推出<span lang=EN-US>150</span>项新开发检测服务。那么，是什么原因让梅奥医学实验室在临床检测开发方面获得如此成功？<span
	lang=EN-US>Morice</span>博士一语道破：<span class=apple-converted-space><b><span
	lang=EN-US>&nbsp;</span></b></span><strong><span style='font-family:"Microsoft YaHei UI",sans-serif'>“<span
	lang=EN-US>We are patient-focused and providing integrated answers, not just
	results</span>”</span></strong>。梅奥诊所每年治疗数百万患者，无论是临床医生、实验室和病理科室，不同的团队都以患者个体化的需求作为一切诊疗和创新的出发点。梅奥医学实验室专注于整合多组学的临床检测数据，协同梅奥诊所的<span
	lang=EN-US>4500</span>位临床医生与科学家，围绕患者的需求制定最佳诊疗整体解决方案，带给患者的是精准检验数字结果背后的医学洞见和最佳诊疗方案。</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt'><strong><span style='font-size:
	11.5pt;font-family:宋体'>十年后的发展趋势</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>作为融资热点的临床诊断领域，未来的机遇在哪里？来自不同国家的专家们在本次论坛的讨论中指出了很多令人兴奋的方向。</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span lang=EN-US
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>Morice</span><span style='font-size:11.5pt;font-family:
	"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'>博士介绍，除了基因组学的分析，<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>包括蛋白质组学、代谢组学等在内的多组学多维分析将是接下来的增长方向</span></strong>，并将成为全球临床诊断新的金标准。</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span lang=EN-US
	style='font-size:11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>van Osch</span><span style='font-size:11.5pt;font-family:
	"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'>先生认为，<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>进一步降低诊断测试的成本和远程诊断技术的突破</span></strong>，可能让患者通过接受诊断检测来防止接受不需要的治疗，从而降低整体诊疗的成本。</span></p>

	<p align=center style='margin:0cm;margin-bottom:.0001pt;text-align:center;
	line-height:21.0pt'><span lang=EN-US style='font-size:13.0pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'><img
	width=100% id="图片 11" src="/images/news/3/image004.png"></span><strong><span
	style='font-size:10.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>▲<span lang=EN-US>Martien van Osch</span>先生，<span
	lang=EN-US>Forbion</span>管理合伙人</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>朱耀毅先生指出，国际上大部分特检项目主要由专业化第三方特检实验室提供，而中国这方面仍处于刚起步的阶段。如果<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>实验室自建检测（<span lang=EN-US>LDT</span>）</span></strong>，也就是由实验室内部开发出体外诊断方法，可以得到开放和普遍推广，将让体外诊断行业有能力应对市场更大的需求，真正达到诊疗配合，促进中国精准医疗的全面发展。</span></p>

	<p align=center style='margin:0cm;margin-bottom:.0001pt;text-align:center;
	line-height:20.4pt'><span lang=EN-US style='font-size:13.0pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'><img
	width=100% id="图片 13" src="/images/news/3/image005.png"></span><span
	lang=EN-US><img width=24 height=24 src="/images/news/3/image006.png"
	alt="https://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gMPiaEkLhhfgTxTiacu5kRicdiawAYpG9gRHJWGC4nzauMYrKibWlM5D8qVKXpEia3sp5EaMHSkQzJmbiaAg/640?wx_fmt=jpeg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span><strong><span
	style='font-size:10.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>▲朱耀毅先生，中国医疗器械行业协会体外诊断分会理事长</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>除了技术创新外，刘道志博士还分享了一些搅局式商业模式的创新案例。例如在中国，城乡差距对诊断的可及性提出了需求。一些敏锐的创新公司通过<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>建立公共服务平台</span></strong>，挖掘城市三甲医院更先进的诊断技术，把快速、高质量的诊断结果送达乡镇医疗需求巨大的病患群体，将“流通”发展成为一个可行的商业模式。</span></p>

	<p align=center style='margin:0cm;margin-bottom:.0001pt;text-align:center;
	line-height:20.4pt'><span lang=EN-US style='font-size:13.0pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'>&nbsp;</span></p>

	<p align=center style='margin:0cm;margin-bottom:.0001pt;text-align:center;
	line-height:20.4pt'><span lang=EN-US style='font-size:13.0pt;
	font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:.4pt'><img
	width=100% id="图片 12" src="/images/news/3/image007.png"></span><span
	lang=EN-US><img width=24 height=24 src="/images/news/3/image008.png"
	alt="https://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gMPiaEkLhhfgTxTiacu5kRicdia63OdXl6md19x4MjLuUD3wQKb8ibhpibkaMMnY68Ck1SwvRSc18QKV7aw/640?wx_fmt=jpeg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span><strong><span
	style='font-size:10.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#0070C0;
	letter-spacing:.4pt'>▲刘釜均博士，药明奥测首席执行官</span></strong></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:20.4pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span style='font-size:
	11.5pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;letter-spacing:
	.4pt'>在讨论的最后，主持人刘釜均博士感谢各位嘉宾提供的洞见。他表示，临床诊断领域的挑战与机遇并存。<strong><span
	style='font-family:"Microsoft YaHei UI",sans-serif'>行业的创新不仅是技术的创新，更应该是商业模式的突破</span></strong>，体外诊断产业亟待创建开放式的平台，快速引进和借鉴国际经验，结合中国医改的实际，高效提高诊断能力，赋能中国医疗迈入精准时代。</span></p>

	<p style='margin:0cm;margin-bottom:.0001pt;text-align:justify;text-justify:
	inter-ideograph;line-height:21.0pt'><span lang=EN-US
	style='font-size:13.0pt;font-family:"Microsoft YaHei UI",sans-serif;color:#333333;
	letter-spacing:.4pt'>&nbsp;</span></p>

	<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

	</div>
</template>

<script>
export default {

};
</script>

<style type="text/css">
@font-face
	{font-family:宋体;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"\@宋体";}
@font-face
	{font-family:"Microsoft YaHei UI";}
@font-face
	{font-family:楷体;}
@font-face
	{font-family:"\@楷体";}
@font-face
	{font-family:"\@Microsoft YaHei UI";}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:10.5pt;
	font-family:"Calibri",sans-serif;}
h2
	{margin-right:0cm;
	margin-left:0cm;
	font-size:18.0pt;
	font-family:宋体;
	font-weight:bold;}
p
	{margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:宋体;}
span.2
	{font-family:宋体;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.5pt;
	font-family:"Calibri",sans-serif;}
 /* Page Definitions */
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	layout-grid:15.6pt;}
div.WordSection1
	{page:WordSection1;}
</style>
